Daniel C. Cattran mostly deals with Internal medicine, Renal function, Kidney disease, Proteinuria and Nephrology. Daniel C. Cattran combines subjects such as Gastroenterology, Endocrinology, Nephropathy and Pathology with his study of Internal medicine. His Renal function study integrates concerns from other disciplines, such as Survival analysis, Surgery, Urology, Glomerulosclerosis and Kidney.
The various areas that Daniel C. Cattran examines in his Kidney disease study include Survival rate, Nephrotic syndrome and Glomerulonephritis. His work deals with themes such as Membranous nephropathy and Intensive care medicine, which intersect with Nephrotic syndrome. His studies in Proteinuria integrate themes in fields like Immunology and Retrospective cohort study.
His primary scientific interests are in Internal medicine, Proteinuria, Renal function, Nephropathy and Kidney disease. His biological study spans a wide range of topics, including Gastroenterology and Endocrinology. In his study, Immunology, Intensive care medicine and Rituximab is strongly linked to Glomerulonephritis, which falls under the umbrella field of Proteinuria.
His research integrates issues of Surgery, Urology, Blood pressure, Creatinine and Kidney in his study of Renal function. His research in Nephropathy intersects with topics in Biopsy, Disease, Cohort, Pathology and Proportional hazards model. Kidney disease is closely attributed to Glomerulosclerosis in his study.
His primary areas of study are Internal medicine, Nephropathy, Proteinuria, Kidney disease and Membranous nephropathy. His Internal medicine research is multidisciplinary, incorporating elements of Gastroenterology and Endocrinology. Daniel C. Cattran interconnects Renal pathology, Renal function and Retrospective cohort study, Cohort, Pathology in the investigation of issues within Nephropathy.
Daniel C. Cattran has included themes like Urology, Immunosuppression, Biopsy, Nephrotic syndrome and Hazard ratio in his Proteinuria study. His Nephrotic syndrome research incorporates elements of Surgery, Glomerulonephritis and Quality of life. Daniel C. Cattran has researched Kidney disease in several fields, including Diabetes mellitus, Guideline, Framingham Risk Score and Intensive care medicine.
Daniel C. Cattran spends much of his time researching Proteinuria, Nephropathy, Internal medicine, Biopsy and Pathology. His Proteinuria research includes elements of Hazard ratio, Nephrotic syndrome, Interquartile range and Renal biopsy. His Nephropathy research includes themes of Retrospective cohort study and Renal function.
The study of Internal medicine is intertwined with the study of Surgery in a number of ways. In his work, Immunology is strongly intertwined with Renal pathology, which is a subfield of Biopsy. His study looks at the relationship between Pathology and fields such as Immunosuppression, as well as how they intersect with chemical problems.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
The Oxford classification of IgA nephropathy: Rationale, clinicopathological correlations, and classification
Daniel C. Cattran;Rosanna Coppo;H. Terence Cook;John Feehally.
Kidney International (2009)
Kidney disease: Improving global outcomes (KDIGO) glomerulonephritis work group. KDIGO clinical practice guideline for glomerulonephritis
Daniel C. Cattran;John Feehally;H. Terence Cook;Zhi Hong Liu.
Kidney International (2012)
The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility
Ian S.D. Roberts;H. Terence Cook;Stéphan Troyanov;Charles E. Alpers.
Kidney International (2009)
Oxford Classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group
Hernán Trimarchi;Jonathan Barratt;Daniel C. Cattran;H. Terence Cook.
Kidney International (2017)
Remission of Proteinuria Improves Prognosis in IgA Nephropathy
Heather N. Reich;Stéphan Troyanov;James W. Scholey;Daniel C. Cattran.
Journal of The American Society of Nephrology (2007)
Randomized Trial of an Inhibitor of Formation of Advanced Glycation End Products in Diabetic Nephropathy
W. Kline Bolton;Daniel C. Cattran;Mark E. Williams;Sharon G. Adler.
American Journal of Nephrology (2004)
Rituximab-induced depletion of anti-PLA2R autoantibodies predicts response in membranous nephropathy.
Laurence H. Beck;Fernando Custodio Fervenza;David M. Beck;Ramon G B Bonegio.
Journal of The American Society of Nephrology (2011)
Predicting progression in IgA nephropathy.
Lukasz P. Bartosik;Ginette Lajoie;Linda Sugar;Daniel C. Cattran.
American Journal of Kidney Diseases (2001)
Cyclosporine in patients with steroid-resistant membranous nephropathy: a randomized trial.
Daniel C. Cattran;Gerald B. Appel;Lee A. Hebert;Lawrence G. Hunsicker.
Kidney International (2001)
The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines--application to the individual patient.
Jai Radhakrishnan;Daniel C. Cattran.
Kidney International (2012)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Mayo Clinic
Columbia University
Vanderbilt University Medical Center
University of Alabama at Birmingham
National Institutes of Health
University of Washington
London School of Hygiene & Tropical Medicine
University of North Carolina at Chapel Hill
University of Bari Aldo Moro
Cedars-Sinai Medical Center
Philipp University of Marburg
DeepMind (United Kingdom)
Microsoft (United States)
University of Rennes
Iowa State University
University of Wollongong
Rutgers, The State University of New Jersey
Stanford University
Greifswald University Hospital
University of Calabria
Scripps Research Institute
University of Auckland
Claude Bernard University Lyon 1
Helmholtz Centre Potsdam - GFZ German Research Centre for Geosciences
Michigan State University
KU Leuven